Back to search

Article

Total intravenous anesthesia in combination with remimazolam and remifentanil without a neuromuscular blocking agent: a prospective observational study

2022-05-10

Abstract excerpt

<h4>Background: </h4> A novel short-acting benzodiazepine, Remimazolam, has recently been approved for general anesthesia and sedation. Hence, we investigated the feasibility and safety of remimazolam during the induction and maintenance of general anesthesia without using a neuromuscular blocking agent (NMBA) in patients undergoing hysteroscopic surgery. <h4>Methods: </h4>: This prospective observational study in...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
c3ce8de1-26c4-5b90-9c0f-86492d310eae
DOI
10.21203/rs.3.rs-1551997/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Total intravenous anesthesia in combination with remimazolam and remifentanil without a neuromuscular blocking agent: a prospective observational studyDOI 10.21203/rs.3.rs-1551997/v1
Select a neighboring publication to make it the new centre.